AI Article Synopsis
- Breast cancer is the most common cancer among women in the UK, with a lifetime risk of 1 in 8, leading to significant health issues and deaths.
- The UK breast screening program has been operational for nearly 30 years and has improved with advancements in diagnostic imaging, but its overall benefits and potential harms remain hotly debated.
- This review aims to inform non-specialist healthcare professionals about the breast screening program's history, its benefits and harms, current diagnostic methods, and possible future developments in screening and imaging techniques.
Article Abstract
Breast cancer is the most commonly diagnosed cancer in women with a lifetime risk of 1 in 8 in the UK. The disease is associated with considerable morbidity and mortality. The UK breast screening program has been in place for almost 30 years and has evolved with improved diagnostic imaging. The overall benefits of the screening program are subject to continued heated debate with multiple potential harms. The aim of this review is to provide the non-breast specialist health-care professional an overview of the evolution of the breast screening program, a summary of the evidence of the benefits, and a description of the harms. In addition, the diagnostic methods currently employed as well as potential future changes to the screening program and imaging techniques will be covered.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/13697137.2017.1342619 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!